First, a bit of background on the pain-drug environment ... That's why, following this recent FDA approval, Vertex stock makes a no-brainer biotech stock to buy and hold for the long term.
Unsurprisingly, investors reacted positively to the latest regulatory victory, with Vertex's shares jumping on Friday. Is this biotech stock a no-brainer buy now after its huge FDA approval?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback